# Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis

> **NCT05177107** · PHASE2 · TERMINATED · sponsor: **Adaptive Phage Therapeutics, Inc.** · enrollment: 41 (actual)

## Conditions studied

- Osteomyelitis
- Diabetic Foot Osteomyelitis

## Interventions

- **BIOLOGICAL:** Bacteriophage Therapy
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05177107
- **Lead sponsor:** Adaptive Phage Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-11-24
- **Primary completion:** 2025-01-30
- **Final completion:** 2025-05-30
- **Target enrollment:** 41 (ACTUAL)
- **Why stopped:** Study reached minimum enrollment threshold
- **Last updated:** 2025-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05177107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05177107, "Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05177107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*